|
|
|
201-500 employees
View all
|
|
pharmaceuticals
|
|
5320 Legacy Dr,Plano,Texas,US
|
|
Reata Pharmaceuticals, Inc. (Nasdaq:RETA) is a clinical-stage biopharmaceutical company that develops novel therapeutics for patients with serious or life-threatening diseases by targeting molecular pathways involved in the regulation of cellular metabolism and inflammation. Reata’s two most advanced clinical candidates, bardoxolone methyl and omaveloxolone, target the important transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation.
|
Reata Pharmaceuticals, Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
85.19%
|
The widely used Reata Pharmaceuticals, Inc. email format is {first}.{last} (e.g. [email protected]) with 85.19% adoption across the company.
To contact Reata Pharmaceuticals, Inc. customer service number in your country click here to find.
Warren Huff is the CEO of Reata Pharmaceuticals, Inc.. To contact Warren Huff email at [email protected] or [email protected]. Or you may call +1.8176015502
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.